Eliot Forster, Ph.D.

Eliot Forster has served as a member of Immatics supervisory board since 2020 and, after the implementation of its one-tier board structure as of July 1, 2021, currently serves as a non-executive director. He is Chief Executive Officer of Levicept Ltd. and is non-executive Chairman of Avacta plc, Ochre Bio, Protalix Inc. and Tessellate Bio.

Eliot has previously served as Chief Executive Officer of F-Star Therapeutics Ltd., Immunocore Ltd., Creabilis SA and Solace Pharmaceuticals Inc. From 2012 to 2020, he has been founding Chairman of MedCity. He is an honorary visiting Professor of Molecular and Clinical Cancer Medicine at the University of Liverpool and an honorary international visiting Professor at the University of Pavia. Additionally, he is a Board member of OSCHR (Office for Strategic Coordination of Health Research) and the National Genomics Board.

Eliot Forster holds a B.Sc. in physiology, a Ph.D. in neurophysiology and an M.B.A. from Henley Business School from the University of Liverpool.